Patients and physicians can also visit a company website and look for their expanded access policy. All companies with products in phase 2 or phase 3 clinical trial in the US are required to have an expanded access policy on their website.
WEP Clinical provides patient advocacy outreach to engage patient organizations and help bring needed treatment to patients around the world. To learn more about our experience working alongside patient advocacy groups, please visit our patient advocacy page.
If you require further information or would like help researching treatment options or reaching out to drug manufacturers, contact us at: